, UNAIDS Global HIV & AIDS statistics-2018 fact sheet
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection, N Engl J Med, vol.338, issue.13, pp.853-860, 1998. ,
Prevention of HIV-1 infection with early antiretroviral therapy, N Engl J Med, vol.365, issue.6, pp.493-505, 2011. ,
Safety and Tolerability: Current Challenges to Antiretroviral Therapy for the Long-Term Management of HIV Infection, AIDS Rev, vol.18, issue.3, pp.127-137, 2016. ,
HIV treatment adherence, drug resistance, virologic failure: evolving concepts, Infect Disord Drug Targets, vol.11, issue.2, pp.167-174, 2011. ,
Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGE h IV cohort study, Clin Infect Dis, vol.59, issue.12, pp.1787-1797, 2014. ,
Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study, J Acquir Immune Defic Syndr, vol.71, issue.2, pp.213-218, 2016. ,
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy, Science, vol.278, issue.5341, pp.1295-1300, 1997. ,
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy, AIDS, vol.13, issue.11, pp.79-86, 1999. ,
The basis for HIV immunotherapeutic vaccines, Vaccine, vol.20, issue.5-6, pp.394-396, 2001. ,
Structure of peptides associated with MHC class I molecules, Curr Opin Immunol, vol.6, issue.1, pp.13-23, 1994. ,
Origin, structure and motifs of naturally processed MHC class II ligands, Curr Opin Immunol, vol.6, issue.1, pp.45-51, 1994. ,
Using HLA binding prediction algorithms for epitope mapping in HIV vaccine clinical trials, BCB '11 Proceedings of the 2nd ACM Conference on Bioinformatics, pp.594-601, 2011. ,
Using Dendritic Cell-based immunotherapy to treat HIV: How can this strategy be improved? Front Immunol, vol.9, p.2993, 2018. ,
Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998. ,
Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine, J Immunol Methods, vol.365, issue.1-2, pp.27-37, 2011. ,
Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized, J Virol, vol.77, issue.20, pp.11220-11231, 2003. ,
HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination, AIDS Res Hum Retroviruses, vol.23, issue.3, pp.427-437, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00529938
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial, AIDS, vol.24, issue.14, pp.2211-2223, 2010. ,
Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load, Eur J Immunol, vol.44, issue.9, pp.2802-2810, 2014. ,
Improved methods for predicting peptide binding affinity to MHC class II molecules, Immunology, vol.154, issue.3, pp.394-406, 2018. ,
Characterization of HIVspecific CD4+ T cell responses against peptides selected with broad population and pathogen coverage, PLoS One, vol.7, issue.7, p.39874, 2012. ,
Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control, J Virol, vol.88, issue.13, pp.7357-7366, 2014. ,
Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection, Vaccine, vol.25, issue.31, pp.5927-5937, 2007. ,
Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies, Hum Immunol, vol.69, issue.7, pp.443-464, 2008. ,
Hierarchy of CD4 T cell epitopes of the ANRS Lipo5 synthetic vaccine relies on the frequencies of pre-existing peptide-specific T cells in healthy donors, J Immunol, vol.190, issue.11, pp.5757-5763, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01109463
Association of HLA-DRB1-restricted CD4 + T cell responses with HIV immune control, Nat Med, vol.19, issue.7, pp.930-933, 2013. ,
A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication, Sci Transl Med, vol.5, issue.166, pp.166-168, 2013. ,
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, J Acquir Immune Defic Syndr, vol.72, issue.1, pp.31-38, 2016. ,
Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells, EBioMedicine, vol.5, pp.46-58, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01438516
Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells, AIDS, vol.27, issue.13, pp.2041-2051, 2013. ,
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates, PLoS One, vol.13, issue.11, p.207794, 2018. ,
TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs, J Clin Invest, vol.128, issue.10, pp.4387-4396, 2018. ,
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change, Curr Opin HIV AIDS, vol.11, issue.6, pp.576-584, 2016. ,